adapalene vs halobetasol
PlainMeds reviewed this comparison against our methodology in August 2026. It places FDA and CMS record fields side by side, without recommending either medication.
Side-by-side comparison of adapalene and halobetasol. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
Differin
Ultravate
No summary available.
Halobetasol Propionate Ointment is a strong steroid medicine used on the skin. It helps reduce swelling, itching, and redness.
Information not available.
This ointment treats skin problems that cause inflammation and itching. These problems are called corticosteroid-responsive dermatoses. Use this medicine for only two weeks at a time. If your skin does not get better in 2 weeks, talk to your doctor.
Information not available.
Halobetasol Propionate Ointment is a corticosteroid. Corticosteroids reduce inflammation. This helps relieve itching and other skin problems.
- • Dry skin
- • Contact dermatitis (skin rash)
- • Burning feeling on the skin where you put the medicine
- • Skin irritation
- • Stinging or burning
- Dry Skin 44,990
- Skin Burning Sensation 41,633
- Acne 39,264
- Erythema 38,379
- Skin Irritation 26,225
- Psoriasis 178
- Itching 115
- Rash 89
- Tiredness 70
- Pain 68
No specific warnings noted.
Using too much Halobetasol Propionate Ointment can affect your adrenal glands. This medicine is very strong. Do not use it for more than two weeks.
No pregnancy information available.
Tell your doctor if you are pregnant or breastfeeding. It is not known if this medicine will harm your unborn baby. Talk to your doctor about the risks and benefits.
Also Compare, Nearby Drugs
Compare adapalene with
How to Read This adapalene vs halobetasol Comparison
adapalene is classified in the Retinoid (Topical) drug class, while halobetasol sits within the Topical Corticosteroid (Superpotent) class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are split between OTC and prescription status, which affects access and supervision.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, adapalene has 190,491 submissions while halobetasol has 520. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. No direct interaction between these two drugs is listed in our FDA-derived dataset, though co-prescription still warrants pharmacist review. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot represent individual circumstances. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This registry does not provide medical, treatment, substitution, or medication-change directions for adapalene or halobetasol.
Registry boundary: This comparison displays source-record fields and does not provide individualized medical direction.